-
Company Insights
New![]()
Innovation and Patenting activity of AP Memory Technology Corp Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of AP Memory Technology Corp Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AP-303 in Diabetic Nephropathy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AP-303 in Diabetic Nephropathy Drug Details: AP-303 is under development for the treatment of diabetic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AP-306 in Hyperphosphatemia In Chronic Kidney Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.AP-306 in Hyperphosphatemia In Chronic Kidney DiseaseDrug Details:AP-306 is under development for the treatment of hyperphosphatemia...
-
Product Insights
New![]()
Bondon
Bondon is an Onshore Wind project located in Norrbotten, Sweden. The project is owned by Bondon 1 Aps Danmark Filial; Bondon Wind ApS Filial Danmark; I/S Bondon 10 Danmark Filial; K/S Bondon 11 og 12 Danmark Filial; K/S Bondon 2; K/S Bondon 5 Danmark Filial; Viby Vind Bondon ApS Danmark Filial and was developed by Global Green Energy A/S. The project came online in 2008. Empower your strategies with our Bondon report and make more profitable business decisions. Note: This...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LX-001 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LX-001 in Solid Tumor Drug Details: AP-002 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NOUS-209 in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. NOUS-209 in Metastatic Colorectal Cancer Drug Details: NOUS-209 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dronabinol in Cancer Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Dronabinol in Cancer PainDrug Details:Dronabinol (AP-THC)Â is under development for the treatment of low back pain,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Resomelagon in Rheumatoid Arthritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Resomelagon in Rheumatoid Arthritis Drug Details: Resomelagon is under development for the treatment of systemic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Resomelagon in Inflammatory Bowel Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Resomelagon in Inflammatory Bowel Disease Drug Details: Resomelagon is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Resomelagon in Peritonitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Resomelagon in Peritonitis Drug Details: Resomelagon is under development for the treatment of systemic inflammatory...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.